Age as a Predictor of Overall Survival in Colorectal Cancer

The diagnosis of colorectal cancer (CRC) at early ages has become a challenging trend for oncology due to high rates of mortality worldwide. The correlation of clinical features with young-age prognosis in CRC remains unclear. Therefore, we aimed to describe the clinicopathological features and thei...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostics (Basel) 2024-11, Vol.14 (22), p.2550
Hauptverfasser: Carbajal-López, Berenice, Coronel-Hernández, Jossimar, Herrera, Marytere, Ruiz-Garcia, Erika, Miyagui-Adame, Sayako M, Diaz-Romero, Consuelo, Madrigal-Santillán, Eduardo Osiris, Esponda-Mendoza, Priscila Morales, Pérez-Plasencia, Carlos, Calderillo-Ruiz, Germán
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The diagnosis of colorectal cancer (CRC) at early ages has become a challenging trend for oncology due to high rates of mortality worldwide. The correlation of clinical features with young-age prognosis in CRC remains unclear. Therefore, we aimed to describe the clinicopathological features and their impact on the overall survival of young Mexican adults diagnosed with CRC treated in the National Cancer Institute. This was a retrospective, observational study. The included patients were treated at the National Cancer Institute between 2004 and 2020. The statistical analyses comprised the X and tests, Kaplan-Meier, log rank, and Cox regression. Statistical significances were assessed when was bilaterally < 0.05. A total of 3652 patients diagnosed with CRC attended the National Cancer Institute. Cases of early onset of CRC increased over the 16 years under study, with significant differences between the median age, from 57 in 2004 to 55 years old in 2020 (F = 5.49; gl: 12 = 0.019). For this analysis, the population was divided in three groups: young (≤30 years), adults (31-70), and elderly (>70). The young population was mostly composed of men (62%; ( = 63), ( = 0.020), with high rates of metastatic disease (44%) ( = 0.001) and right-side tumors (57%), ( = 0.046), and with 44% with a moderate grade ( = 0.750). According to the overall survival (OS) analysis, the median OS was 29 months for young, versus 170 months for adult and 56 months for elderly patients (
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics14222550